for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

Novavax to supply 40 mln doses of COVID-19 vaccine to Australia

Nov 4 (Reuters) - Novavax Inc said on Wednesday it has signed an agreement with the Australian Government to supply 40 million doses of the its COVID-19 vaccine candidate, NVX-CoV2373.

Under the agreement, the company will deliver its vaccine to Australia starting as early as the first half of 2021, Novavax said.

The company added it expects to report late-stage data from its UK trial as soon as the first quarter of 2021.

Reporting by Dania Nadeem in Bengaluru; Editing by Aditya Soni

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up